Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.32B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$2.19B |
| 3 |
Apple
AAPL
|
+$2.17B |
| 4 |
NVIDIA
NVDA
|
+$2.12B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.74B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares China Large-Cap ETF
FXI
|
+$563M |
| 2 |
Jefferies Financial Group
JEF
|
+$510M |
| 3 |
SPDR Gold Trust
GLD
|
+$313M |
| 4 |
S&P Global
SPGI
|
+$286M |
| 5 |
CrowdStrike
CRWD
|
+$196M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.69% |
| 2 | Consumer Discretionary | 7.38% |
| 3 | Financials | 7.04% |
| 4 | Healthcare | 5.93% |
| 5 | Communication Services | 4.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4726
Saga Communications
SGA
$55.6M
| $45.1K | ﹤0.01% |
3,620
-915
| -20% | -$11K |
|
4727
Expensify
EXFY
$175M
| $45.1K | ﹤0.01% |
14,826
-179,303
| -92% | -$623K |
|
|
OKLO
4728
Oklo
OKLO
$6.98B
| $45K | ﹤0.01% |
2,082
-7,950
| -79% | -$269K |
|
4729
GrowGeneration
GRWG
$88.9M
| $45K | ﹤0.01% |
41,679
-3,431
| -8% | -$4.6K |
|
4730
State Street SPDR S&P Emerging Asia Pacific ETF
GMF
$418M
| $44.9K | ﹤0.01% |
388
-136
| -26% | -$15.8K |
|
4731
Telomir Pharmaceuticals
TELO
$83.2M
| $44.8K | ﹤0.01% |
13,885
-1,351
| -9% | -$5.91K |
|
4732
XBiotech
XBIT
$69.8M
| $44.8K | ﹤0.01% |
13,824
-1,545
| -10% | -$5.33K |
|
4733
First Trust Exchange-Traded Fund II First Trust International Equity Opportunities ETF
FPXI
$266M
| $44.7K | ﹤0.01% |
950
| – | – |
|
4734
Lexicon Pharmaceuticals
LXRX
$999M
| $44.7K | ﹤0.01% |
96,968
-9,818
| -9% | -$6.19K |
|
4735
Fidelity Enhanced Mid Cap Core ETF
FMDE
$7.74B
| $44.5K | ﹤0.01% |
+1,421
| New | +$47.1K |
|
4736
The ONE Group
STKS
$56.2M
| $44.4K | ﹤0.01% |
14,858
-1,896
| -11% | -$5.97K |
|
4737
Corbus Pharmaceuticals
CRBP
$168M
| $44.1K | ﹤0.01% |
8,298
-912
| -10% | -$8.05K |
|
4738
Aemetis
AMTX
$106M
| $44.1K | ﹤0.01% |
25,320
-2,871
| -10% | -$6.14K |
|
|
LNAI
4739
Lunai Bioworks
LNAI
$10.4M
| $43.7K | ﹤0.01% |
1,005
-1,339
| -57% | -$85.7K |
|
4740
Cabaletta Bio
CABA
$440M
| $43.6K | ﹤0.01% |
31,462
-4,292
| -12% | -$9.14K |
|
|
HDL
4741
Super Hi International Holding
HDL
$765M
| $43.2K | ﹤0.01% |
1,891
| – | – |
|
|
JBIO
4742
Jade Biosciences
JBIO
$1.17B
| $43.1K | ﹤0.01% |
491
+28
| +6% | +$2.46K |
|
4743
Biomea Fusion
BMEA
$91.8M
| $43.1K | ﹤0.01% |
20,223
-3,216
| -14% | -$11K |
|
|
ARTV
4744
Artiva Biotherapeutics
ARTV
$507M
| $43K | ﹤0.01% |
14,338
-1,268
| -8% | -$6.85K |
|
4745
Mastech Digital
MHH
$92.5M
| $42.9K | ﹤0.01% |
4,199
-3,545
| -46% | -$43.3K |
|
4746
Lifetime Brands
LCUT
$197M
| $42.9K | ﹤0.01% |
8,693
-898
| -9% | -$4.87K |
|
4747
Fidus Investment
FDUS
$758M
| $42.8K | ﹤0.01% |
2,101
+165
| +9% | +$3.62K |
|
|
VCSA
4748
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $42.8K | ﹤0.01% |
7,960
+166
| +2% | +$858 |
|
|
NOTE
4749
DELISTED
FiscalNote
NOTE
| $42.8K | ﹤0.01% |
4,409
+219
| +5% | +$3.29K |
|
4750
Champions Oncology
CSBR
$78.2M
| $42.7K | ﹤0.01% |
+4,915
| New | +$49.8K |
|
Similar funds
Citigroup's Q1 2025 Portfolio in Review
As of Q1 2025, Citigroup held 6,124 positions worth $196B, up 16% from $169B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Citigroup deployed $38.1B of net new capital in Q1 2025, opening 294 new positions and adding to 2,193 existing holdings. Its largest new stake was Boeing Co 6.00% Series A Preferred Stock: 2,013,956 shares worth $120M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares China Large-Cap ETF, an estimated $563M trimmed.
- Citigroup's largest Q1 2025 buy was Boeing Co 6.00% Series A Preferred Stock: 2,013,956 shares worth $120M.
- Citigroup added most to Microsoft in Q1 2025, an estimated $2.32B increase.
- Citigroup's biggest Q1 2025 reduction was iShares China Large-Cap ETF, cutting an estimated $563M.
- Citigroup fully exited Retail Opportunity Investments Corp. in Q1 2025, selling an estimated $46.9M.
- Citigroup's ten largest holdings make up 24% of its $196B portfolio in Q1 2025.
- Citigroup opened 294 new positions and closed 585 in Q1 2025.
- Citigroup's portfolio value rose 16% quarter-over-quarter to $196B.
Based on Citigroup's 13F filing for Q1 2025, filed 12 May 2025.